Congratulations to our Clinical Director Dr. Cora N. Sternberg (@cnsternberg) on her new @JCO_ASCO paper, "Phase I/II Study of #Bavdegalutamide, a #PROTAC Androgen Receptor Degrader, in Metastatic Castration-Resistant #ProstateCancer."
@wcmenglanderipm.bsky.social